Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure

Table 1

Baseline characteristics of subjects.

Group		𝑛	Age (years)	BMI (kg/m^2)
Control subjects	UW	5	73.8±11.9	19.2±0.9
	NW	14	72.6±10.4	22.0±1.1
	OW	3	74.0±8.7	28.5±2.4
COPD	UW	10	76.2±5.0	18.3±1.2
	NW	23	73.2±10.4	21.7±1.4
	OW	7	74.7±7.0	26.2±0.9